These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 9751607)
1. Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogenesis and tumor growth. Nie D; Hillman GG; Geddes T; Tang K; Pierson C; Grignon DJ; Honn KV Cancer Res; 1998 Sep; 58(18):4047-51. PubMed ID: 9751607 [TBL] [Abstract][Full Text] [Related]
2. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma. Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression. Pidgeon GP; Tang K; Cai YL; Piasentin E; Honn KV Cancer Res; 2003 Jul; 63(14):4258-67. PubMed ID: 12874035 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells. Pidgeon GP; Kandouz M; Meram A; Honn KV Cancer Res; 2002 May; 62(9):2721-7. PubMed ID: 11980674 [TBL] [Abstract][Full Text] [Related]
6. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors. Matsuyama M; Yoshimura R; Mitsuhashi M; Hase T; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T Int J Oncol; 2004 Apr; 24(4):821-7. PubMed ID: 15010818 [TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor production in human prostate cancer cells is stimulated by overexpression of platelet 12-lipoxygenase. McCabe NP; Selman SH; Jankun J Prostate; 2006 May; 66(7):779-87. PubMed ID: 16482570 [TBL] [Abstract][Full Text] [Related]
8. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948 [TBL] [Abstract][Full Text] [Related]
9. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia. Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584 [TBL] [Abstract][Full Text] [Related]
10. Platelet-type 12-lipoxygenase accelerates tumor promotion of mouse epidermal cells through enhancement of cloning efficiency. Piao YS; Du YC; Oshima H; Jin JC; Nomura M; Yoshimoto T; Oshima M Carcinogenesis; 2008 Feb; 29(2):440-7. PubMed ID: 18174253 [TBL] [Abstract][Full Text] [Related]
11. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model. McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910 [TBL] [Abstract][Full Text] [Related]
12. Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells. Liu N; Gao F; Han Z; Xu X; Underhill CB; Zhang L Cancer Res; 2001 Jul; 61(13):5207-14. PubMed ID: 11431361 [TBL] [Abstract][Full Text] [Related]
13. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Deryugina EI; Soroceanu L; Strongin AY Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713 [TBL] [Abstract][Full Text] [Related]
14. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938 [TBL] [Abstract][Full Text] [Related]
15. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase. Igawa T; Lin FF; Rao P; Lin MF Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404 [TBL] [Abstract][Full Text] [Related]
16. Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells. Ding XZ; Iversen P; Cluck MW; Knezetic JA; Adrian TE Biochem Biophys Res Commun; 1999 Jul; 261(1):218-23. PubMed ID: 10405349 [TBL] [Abstract][Full Text] [Related]
17. Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase. Nie D; Nemeth J; Qiao Y; Zacharek A; Li L; Hanna K; Tang K; Hillman GG; Cher ML; Grignon DJ; Honn KV Clin Exp Metastasis; 2003; 20(7):657-63. PubMed ID: 14669797 [TBL] [Abstract][Full Text] [Related]
18. Modulation of tumor angiogenesis by conditional expression of fibroblast growth factor-2 affects early but not established tumors. Giavazzi R; Giuliani R; Coltrini D; Bani MR; Ferri C; Sennino B; Tosatti MP; Stoppacciaro A; Presta M Cancer Res; 2001 Jan; 61(1):309-17. PubMed ID: 11196179 [TBL] [Abstract][Full Text] [Related]
19. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription. Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618 [TBL] [Abstract][Full Text] [Related]
20. Stimulation of tumor growth by human soluble intercellular adhesion molecule-1. Gho YS; Kim PN; Li HC; Elkin M; Kleinman HK Cancer Res; 2001 May; 61(10):4253-7. PubMed ID: 11358852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]